Issue Date: May 5, 2014
Antibiotic May Sidestep Resistance
Researchers finally know exactly how the promising antibiotic GE23077 (GE) inhibits an essential bacterial enzyme. They predict that GE’s ability to hit this enzyme in its active site could make it difficult for bacteria to develop resistance to the agent. The study also shows how GE might be conjugated with another antibiotic to make a combination drug the scientists believe might be unusually resistance-proof.
Some bacterial infections are difficult or impossible to treat effectively because . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society